SHE:300653 - Yantai Zhenghai Bio-Tech Co Ltd

Yantai Zhenghai Bio-Tech Co Lt
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q2	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	98.85M -3.2%	100.05M 1.2%	99.15M -0.9%	117.73M 18.7%	113.7M -3.4%	109.84M -3.4%	91.94M -16.3%	109.08M 18.6%	115.43M 5.8%	97.28M -15.7%	91.87M -5.6%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	9.93M 15.6%	11.33M 14.0%	13.74M 21.4%	12.88M -6.3%	14.18M 10.0%	11.39M -19.7%	10.41M -8.6%	11.14M 7.1%	10.64M -4.6%	9.14M -14.1%	10.86M 18.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	88.92M -4.9%	88.72M -0.2%	85.41M -3.7%	104.85M 22.8%	99.53M -5.1%	98.46M -1.1%	81.53M -17.2%	97.94M 20.1%	104.79M 7.0%	88.14M -15.9%	81.01M -8.1%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	58.12M 8.5%	55.64M -4.3%	58.3M 4.8%	57.26M -1.8%	62.71M 9.5%	57.85M -7.7%	50.25M -13.1%	55.4M 10.2%	59.04M 6.6%	58.09M -1.6%	48.36M -16.7%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	48.19M 7.2%	44.32M -8.0%	44.56M 0.6%	44.38M -0.4%	48.53M 9.4%	46.46M -4.3%	39.84M -14.3%	44.25M 11.1%	48.41M 9.4%	48.96M 1.1%	37.51M -23.4%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	40.73M -16.2%	44.41M 9.0%	40.85M -8.0%	60.47M 48.0%	51M -15.7%	51.99M 2.0%	41.7M -19.8%	53.68M 28.7%	56.38M 5.0%	39.18M -30.5%	43.51M 11.0%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	81.09M -	-	-	-	104.08M -	-	-	-	109.84M -	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	37.1M -15.7%	45.35M 22.3%	42.11M -7.2%	55.02M 30.7%	49.06M -10.8%	51.27M 4.5%	30.08M -41.3%	53.4M 77.5%	56.44M 5.7%	38.49M -31.8%	42.62M 10.7%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.203 -17.6%	0.25 23.0%	0.24 -4.0%	0.31 29.2%	0.27 -12.9%	0.28 3.7%	0.42 50.0%	0.3 -28.6%	0.31 3.3%	0.21 -32.3%	0.24 14.3%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.203 -17.6%	0.25 23.0%	0.24 -4.0%	0.31 29.2%	0.27 -12.9%	0.28 3.7%	0.42 50.0%	0.3 -28.6%	0.31 3.3%	0.21 -32.3%	0.24 14.3%